Monoclonal antibody Nd2
Latest Information Update: 28 Jun 2011
At a glance
- Originator Tosoh
- Class Antineoplastics; Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Immunostimulants; Radionuclide imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Pancreatic cancer